Will endometrial polyps recur after surgery?

Endometrial polyps have a certain possibility of recurrence after surgical resection, especially when the relevant pathogenic factors are not improved or the patient is in a high-risk group. Effective prevention of recurrence requires a combination of postoperative health management and intervention targeting the cause.

The reasons for the recurrence of endometrial polyps are mainly related to the following points: genetic factors may make some women more prone to endometrial hyperplasia; environmental factors such as long-term exposure to harmful chemicals or environments with high estrogen levels will also increase the risk of polyp formation; physiological factors such as obesity, endocrine disorders, high estrogen levels or luteal insufficiency; pathological factors such as women with polycystic ovary syndrome or chronic endometritis are more likely to relapse. Incomplete surgical resection may also leave hidden dangers for polyp recurrence. Recurrence is often related to comprehensive and multifaceted factors.

The reasons for the recurrence of endometrial polyps are mainly related to the following points: genetic factors may make some women more prone to endometrial hyperplasia; environmental factors such as long-term exposure to harmful chemicals or environments with high estrogen levels will also increase the risk of polyp formation; physiological factors such as obesity, endocrine disorders, high estrogen levels or luteal insufficiency; pathological factors such as women with polycystic ovary syndrome or chronic endometritis are more likely to relapse. Incomplete surgical resection may also leave hidden dangers for polyp recurrence. Recurrence is often related to comprehensive and multifaceted factors.

Preventing recurrence requires a multi-faceted approach. Regular postoperative review of endometrial B-ultrasound, especially 3-6 months after surgery is a critical period; for women with high estrogen levels, it is recommended to use progesterone drugs to regulate endocrine according to the doctor's instructions, such as medroxyprogesterone acetate, dydrogesterone or levonorgestrel intrauterine device; patients with chronic inflammation can cooperate with anti-inflammatory treatment after surgery, such as the use of cephalosporin antibiotics, metronidazole, etc. for infection control. Improving eating habits, reducing fat intake and increasing dietary fiber, maintaining regular exercise, and controlling weight are all important measures to reduce the risk of recurrence. For patients with repeated recurrences in the past, medication combined with conservative treatment can also be considered to avoid surgery in the long term. In short, preventing the recurrence of polyps requires collaboration from multiple parties, and patients are advised to follow the doctor's instructions and manage their condition in an individualized manner.